Nicki Badii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicki Badii has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Danny William Wilson
Reseach Centre for Infectious Diseases, School of Biological Sciences, Adelaide University, Adelaide 5005, Australia
1 shared publication - Dimuthu Angage
Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Sciences, La Trobe University
1 shared publication - Isabelle G. Henshall
Pathogen section, Bernhard Nocht Institute for Tropical Medicine
1 shared publication - James G. Beeson
Life Sciences, Burnet Institute, Melbourne, Australia
1 shared publication - Jill Chmielewski
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
1 shared publication - Kaitlin R Turland
Research Centre for Infectious Diseases, School of Biological Sciences, Adelaide University
1 shared publication
Latest Publications
- Open Access
- 27 July 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies
Malaria merozoite surface proteins (MSPs) are thought to have important roles in red blood cell (RBC) invasion and their exposure on the parasite surface makes them attractive vaccine candidates. However, their role in invasion has not been directly demonstrated and their biological functions remain unknown. One of the most abundant merozoite surface proteins is Pf MSP2, a likely ancestral protein that has been maintained in the Plasmodium falciparum lineage and is a focus of vaccine development. Using CRISPR-Cas9 gene editing, we removed Pf MSP2 from two different P. falciparum lines with no impact on parasite replication or phenotype in vitro, demonstrating that it is not essential for RBC invasion. Interestingly, loss of Pf MSP2 led to increased inhibitory potency of antibodies targeting other merozoite proteins involved in invasion, particularly Pf AMA1. In a solid-phase model, increasing concentrations of Pf MSP2 protein reduced binding of different antibodies against Pf AMA1 in a dose-dependent manner. These data suggest that Pf MSP2 can modulate the susceptibility of merozoites to protective inhibitory antibodies. The results of this study change our understanding of the potential functions of Pf MSP2 and establish a new concept in malaria where a surface protein can reduce the protective efficacy of antibodies targeting a different antigen. These findings have important implications for understanding malaria immunity and informing vaccine development.
- 27 July 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Open AccessAn abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies
Malaria merozoite surface proteins (MSPs) are thought to have important roles in red blood cell (RBC) invasion and their exposure on the parasite surface makes them attractive vaccine candidates. However, their role in invasion has not been directly demonstrated and their biological functions remain unknown. One of the most abundant merozoite surface proteins is Pf MSP2, a likely ancestral protein that has been maintained in the Plasmodium falciparum lineage and is a focus of vaccine development. Using CRISPR-Cas9 gene editing, we removed Pf MSP2 from two different P. falciparum lines with no impact on parasite replication or phenotype in vitro, demonstrating that it is not essential for RBC invasion. Interestingly, loss of Pf MSP2 led to increased inhibitory potency of antibodies targeting other merozoite proteins involved in invasion, particularly Pf AMA1. In a solid-phase model, increasing concentrations of Pf MSP2 protein reduced binding of different antibodies against Pf AMA1 in a dose-dependent manner. These data suggest that Pf MSP2 can modulate the susceptibility of merozoites to protective inhibitory antibodies. The results of this study change our understanding of the potential functions of Pf MSP2 and establish a new concept in malaria where a surface protein can reduce the protective efficacy of antibodies targeting a different antigen. These findings have important implications for understanding malaria immunity and informing vaccine development.